explore -WSS

explore

author：fashion 2025-09-05 13:46:11 - browse：41553

LONDON — AstraZeneca said Tuesday it would acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on the booming area of targeted radiation therapies for cancer.

AstraZeneca will pay $2 billion in cash upfront for Fusion, a price that at $21 a share is nearly double Fusion’s closing share price on Monday. If certain regulatory milestones are met, AstraZeneca will pay another $3 a share, or roughly $400 million.

Fusion specializes in developing radiopharmaceuticals, also known as radioconjugates or radioligands, which deliver radiation directly to tumors, guided by particular markers on cancer cells. The aim is not only to minimize the risk of damaging surrounding, healthy tissue, but also to reach tumors that traditional radiation can’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Manchin plays down potential 3rd

leisure time

WSS

Why you get paid to donate plasma but not blood

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

AI can’t replace a physician’s gut feeling

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Medicare to cover more brain scans for Alzheimer’s patients

At Orexo, a ‘turning point’ for everything but digital health

explore

explore

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

After affirmative action ruling, medical educators look to 'holistic review'

Medicare has a new plan to address drug shortages

Medical records are filled with copy

WHO calls for emergency meeting on new China virus, as cases spread

Wildfire smoke exposes gaps in outdoor worker protections

FDA approves RSV monoclonal antibody for infants, toddlers

Medicare proposal to cover medical devices draws a mixed reaction

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

focus

15 die by electrocution after transformer explodes in northern India

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Doctors find melanoma drugs effective against rare brain cancer

Sanofi seeks simpler, safer CRISPR sickle cell cure

Key House panel plots a new health care package

FDA seeking to stop procedures at two unregulated stem cell clinics

leisure time

Wikipedia

focus

explore